Consumer sentiment is flashing recession warnings, yet three blue-chip dividend legends are quietly building cases for returns that would shock most defensiv...
Quick Read <ul><li>PG and JNJ target $180 and $300 respectively, with JNJ's oncology pipeline posting drug growth up to 83% in Q1. </li><li>KO's FIFA World Cup 2026 activation across 180+ markets, …
